Deflectable Catheters Market Aims for US$ 2.4 Billion Valuation by 2029

Deflectable Catheters Market

By 2029, the deflectable catheter market trends is expected to develop at a compound annual growth rate (CAGR) of 3.9% worldwide. By 2029, deflectable catheter sales are expected to reach a market valuation of US$ 2.4 billion, up from the current predicted US$ 1.8 billion.

Because deflectable catheters can be used in a wide range of medical procedures, the market for them is expanding significantly. Because of the flexible tip’s remote control architecture, these catheters enable accurate navigation via complex anatomical paths. This technology has improved the ability of physicians to access difficult areas of the body, hence revolutionising minimally invasive surgeries.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-5852

Several factors are driving the growth of the deflectable catheters market. One of the primary drivers is the increasing adoption of minimally invasive procedures. As patients and healthcare providers seek less invasive alternatives to traditional surgeries, deflectable catheters offer a solution by enabling procedures that require smaller incisions, reduced pain, and faster recovery times.

Companies Eyeing Untapped Opportunities in Cost-sensitive Regional Markets The current adoption pattern among healthcare professionals favour the use of reposable medical devices, a trend that is most certainly observed in developing countries, to complement the cost factor and availability. In contrast, most of the deflectable catheters used are one-time use products. Factors like blood, debris prevent using reposable deflectable catheters in operations as critical as electrophysiology.

The usage of reposable deflectable catheters is significantly higher in developing economies with inadequate resources, where the cost of treatment can be significantly high, which is unfavourable for patients from poor backgrounds. The present cost structure with the use of reposable deflectable catheters makes it feasible for a sizeable population to opt for low-cost treatment options, which help boost the adoption rate, and thereby expand the consumer pool.

At present, there are only a few companies offering reposable deflectable catheters, and none of the major players are into developing reposable devices. As per the report, a comparatively smaller company, CathRx, has a similar reposable product, Khelix, which is considered to be the first ‘reposable’ diagnostic and therapeutic catheter for the treatment of cardiac arrhythmias.

Acquisitions & Collaborations Playing Decisive Role in Shaping Deflectable Catheters Market Structure

The affective adjustments and development observed in the parent market influences the deflectable catheters market. The recent trend of involving digital methods for diagnosing cardiac problems is also changing the treatment pattern. All these trends are more governed by the top market leaders in the cardiology market. With abundant resources and investment plans, they manipulate the industry in a way in which no other smaller or regional manufacturer is capable of keeping pace with them.

The trend of acquisition and forming a strategic partnership is positive delivering financial results. For example, Abbott’s acquisition of St. Jude Medical resulted in the consolidation of the 2nd and 4th largest cardiology market players. Moreover, the acquisition of specific treatment technologies has also been observed in the deflectable catheter market, and there has been an increase in the number of players expanding their product portfolio for the treatment of atrial fibrillation/atrial flutter.

Deflectable Catheters Market: Segmental Analysis

On the basis of product type, the deflectable catheters market has been segmented into uni-directional deflectable catheters, bi-directional deflectable catheters, and multi-directional deflectable catheters. Bi-directional deflectable catheters lead the market due to their high adoption rate and availability.

Based on application, the deflectable catheters market has been segmented into coronary interventions, electrophysiology, diagnostics imaging, and peripheral interventions. In terms of revenue, the electrophysiology segment is expected to have a major share in the deflectable catheters market due to an increase in the number of procedures being carried out by deflectable catheters.

On the basis of end user, the deflectable catheters market has been categorised into hospitals, office-based clinics, ambulatory surgical centres, and independent catheterisation labs. Independent catheterisation labs are expected to witness significant growth, which is driven by an increase in the number of the same.

Key Players :

• Medtronic Plc.
• Merit Medical Systems
• Biosense Webster Inc.
• Teleflex Incorporated
• Boston Scientific Corporation
• Biomerics LLC
• OSYPKA AG
• Abbot
• Japan Lifeline Co.
• CathRx Ltd.
• Biotronik SE & Co. KG.

Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5852

Key Segments:

• Uni-Directional Deflectable Catheters
• Bi-Directional Deflectable Catheters
• Multi-Directional Deflectable Catheters

Deflectable Catheters Market by Application:

• Deflectable Catheters for Coronary Interventions
• Deflectable Catheters for Electrophysiology
• Deflectable Catheters for Diagnostics Imaging
• Deflectable Catheters for Peripheral Interventions

Deflectable Catheters Market by End User:

• Deflectable Catheters for Hospitals
• Deflectable Catheters for Office-based Clinics
• Deflectable Catheters for Ambulatory Surgical Centres
• Deflectable Catheters for Independent Catheterization Labs

Deflectable Catheters Market by Region:

• North America Deflectable Catheters Market
• Latin America Deflectable Catheters Market
• Europe Deflectable Catheters Market
• East Asia Deflectable Catheters Market
• South Asia & Pacific Deflectable Catheters Market
• Middle East & Africa (MEA) Deflectable Catheters Market

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube